Feature|Articles|October 8, 2023
- Pharmaceutical Executive: October 2023
- Volume 43
- Issue 10
Pharmaceutical Executive, October 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive October 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 2 years ago
A Blueprint for Balanceover 2 years ago
Biopharma Stock Check: Market Review and Outlookover 2 years ago
Securing the Safety Net in Drug Access and Supportover 2 years ago
Obesity Drugs in the Payer Market: What to Expectover 2 years ago
Boosting Clinical Trials and Patient Access with Payer Insightsover 2 years ago
Are We Close to a Peak in Interest Rates?over 2 years ago
The Harms of ‘Helicopter Research’ in the Life Sciencesover 2 years ago
The Rising Importance of Patient Advocacy Innovations in Asiaover 2 years ago
A Fond FarewellAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
3
The Risks and Benefits of FDA Reviewing Real-Time Data
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5